Drug eradicated breast, skin cancer in trial

aol.com

An experimental drug injected into tumors eliminated aggressive breast and skin cancer in a small trial. The drug, an enhanced CD40 agonist, caused tumors to shrink in six of twelve participants and led to complete remission in two. It showed limited side effects. This immunotherapy approach aims to activate the immune system against cancer. Larger trials are underway to confirm its effectiveness and safety across various cancer types.


With a significance score of 5, this news ranks in the top 1.5% of today's 28195 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: